Natera, Inc. (NTRA)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$200.17
-1.66%
Mkt Cap $28.37B
Analyst Ratings
Buy
20
Hold
3
Sell
0
Price Target (31 analysts)
$249.57
Range $172.00 – $285.00
Implied Upside
+24.7%
Consensus $249.57 vs current $200.17